New York State Common Retirement Fund
IMPL

New York State Common Retirement Fund’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

New York State Common Retirement Fund’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-45
Closed – – 3517
2022
Q2 		$0 Sell
45
-6,802
-99% -$49.7K ﹤0.01% 3569
2022
Q1 		$44K Sell
6,847
-20
-0.3% -$151 ﹤0.01% 3195
2021
Q4 		$59K Hold
6,867
– – ﹤0.01% 3194
2021
Q3 		$84K Sell
6,867
-6,833
-50% -$99.2K ﹤0.01% 3180
2021
Q2 		$121K Buy
+13,700
New +$164K ﹤0.01% 3181

Other funds holding IMPL

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return
LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

New York State Common Retirement Fund's IMPL Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q3 2022, closing a stake of 45 shares.

New York State Common Retirement Fund first reported a position in IMPL in Q2 2021 and held it in 5 quarters. The position peaked at $121K in Q2 2021. 39 funds tracked by Wall St. Rank hold IMPL as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 45 Impel Pharmaceuticals Inc. Common Stock shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • New York State Common Retirement Fund's Impel Pharmaceuticals Inc. Common Stock position peaked at $121K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.